New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 19, 2014
11:32 EDTILMN, SQNM, PKI, LHLabCorp prenatal test a negative for Sequenom, says Maxim
Maxim views LabCorp's (LH) announcement today that it will begin offering the informaSeq prenatal test as a long-term negative for Sequenom (SQNM) due to increased competition. The news is also negative for Illumina (ILMN) and PerkinElmer (PKI), who both offer Non-Invasive Prenatal Tests, Maxim adds. The firm recommends buying shares of LabCorp and keeps a Buy rating on the name with a $130 price target.
News For LH;SQNM;ILMN;PKI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 3, 2015
09:12 EDTLHNeoGenomics overhang should dissipate, says Roth Capital
Subscribe for More Information
08:46 EDTLHLabCorp expands partnership with PTQ
Subscribe for More Information
September 2, 2015
07:05 EDTSQNMSequenom announces partnership with Perinatal Quality Foundation
Subscribe for More Information
August 28, 2015
16:40 EDTSQNMSequenom files $300M mixed securities shelf
Subscribe for More Information
August 27, 2015
10:00 EDTPKI, ILMNOn The Fly: Analyst Initiation Summary
Subscribe for More Information
August 26, 2015
16:20 EDTPKIPerkinElmer initiated with a Buy at Cantor
Target $62.
16:12 EDTILMNIllumina initiated with a Buy at Cantor
Target $265.
07:28 EDTILMNIllumina added to Focus List at Citi
Subscribe for More Information
August 25, 2015
17:32 EDTSQNMSequenom enters collaboration with UC San Diego Moores Cancer Center
Subscribe for More Information
05:09 EDTILMNIllumina enters oncology collaboration with Burning Rock
Subscribe for More Information
August 24, 2015
16:17 EDTLHLabCorp: Covance announces agreement with leading pharmaceutical company
Laboratory Corporation of America Holdings announced that Covance Drug Development has received a multi-year award from a leading pharmaceutical company to use Covance's Xcellerate platform as an exclusive central monitoring solution for their worldwide clinical trials portfolio. This landmark agreement with a top-tier pharmaceutical company for Covance's first-in-kind Software-as-a-Service offering reflects the company's unique technology capabilities, and reinforces its position as an industry innovator and leader in clinical informatics solutions.
08:45 EDTLHLabCorp announces availability of VistaSeq Hereditary Cancer Panel
Subscribe for More Information
08:29 EDTSQNM, ILMNWilliam Blair to hold a field trip
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use